NCT01573403View on ClinicalTrials.gov

Efficacy and Safety of DLBS2411 in Healthy Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Gastric pH Regulation in Healthy Volunteers
Interventions
DRUG

DLBS2411

1 caplet of DLBS2411 @250 mg and 1 placebo caplet, once daily

DRUG

DLBS2411

2 caplets of DLBS2411 @250 mg, once daily

DRUG

Placebo DLBS2411

2 placebo caplets of DLBS2411, once daily

Trial Locations (1)

10430

Division of Gastroenterology, Department of Internal Medicine, dr. Cipto Mangunkusumo Hospital, Jakarta Center

Sponsors

Lead Sponsor

Dexa Medica Group
All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT01573403 - Efficacy and Safety of DLBS2411 in Healthy Volunteers | Biotech Hunter | Biotech Hunter